par Cavalier, Etienne;Kaufman, Jean-Marc;Nzeusseu Toukap, Adrien;Reginster, Jean-Yves;Rousseau, A.F.;Rozenberg, Serge 
;Scheen, André Jacques;Body, Jean-Jacques ;Bergmann, Pierre ;Bruyere, Olivier;Delanaye, Pierre;Durnez, A;Devogelaer, Jean-Pierre;Ferrari, Serge Livio Ivio S.L.;Gielen, Evelien;Goemaere, Stefan
Référence Osteoporosis international, 27, 7, page (2181-2195)
Publication Publié, 2016-07
;Scheen, André Jacques;Body, Jean-Jacques ;Bergmann, Pierre ;Bruyere, Olivier;Delanaye, Pierre;Durnez, A;Devogelaer, Jean-Pierre;Ferrari, Serge Livio Ivio S.L.;Gielen, Evelien;Goemaere, StefanRéférence Osteoporosis international, 27, 7, page (2181-2195)
Publication Publié, 2016-07
Article révisé par les pairs
| Résumé : | The exact role of biochemical markers of bone turnover in the management of metabolic bone diseases remains a topic of controversy. In this consensus paper, the Belgian Bone Club aimed to provide a state of the art on the use of these biomarkers in different clinical or physiological situations like in postmenopausal women, osteoporosis in men, in elderly patients, in patients suffering from bone metastasis, in patients with chronic renal failure, in pregnant or lactating women, in intensive care patients, and in diabetics. We also gave our considerations on the analytical issues linked to the use of these biomarkers, on potential new emerging biomarkers, and on the use of bone turnover biomarkers in the follow-up of patients treated with new drugs for osteoporosis. |
